Found: 24
Select item for more details and to access through your institution.
Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 Influenza Seasons.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 3, p. 778, doi. 10.1093/cid/ciae180
- By:
- Publication type:
- Article
Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0252836
- By:
- Publication type:
- Article
Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0248943
- By:
- Publication type:
- Article
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 216, doi. 10.3390/vaccines12020216
- By:
- Publication type:
- Article
Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1607, doi. 10.3390/vaccines11101607
- By:
- Publication type:
- Article
Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101610
- By:
- Publication type:
- Article
Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1456, doi. 10.3390/vaccines10091456
- By:
- Publication type:
- Article
Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060896
- By:
- Publication type:
- Article
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease.
- Published in:
- Neuroepidemiology, 2007, v. 28, n. 4, p. 193, doi. 10.1159/000108110
- By:
- Publication type:
- Article
Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019–2020 US Influenza Season.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 8, p. 1, doi. 10.1093/ofid/ofae459
- By:
- Publication type:
- Article
Number of Influenza Risk Factors Informs an Adult's Increased Potential of Severe Influenza Outcomes: A Multiseason Cohort Study From 2015 to 2020.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae203
- By:
- Publication type:
- Article
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae175
- By:
- Publication type:
- Article
Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad429
- By:
- Publication type:
- Article
Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18–64 Years During the 2019–2020 US Influenza Season.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad304
- By:
- Publication type:
- Article
O2-06-04: Amyloid β42-level lowering non-steroidal anti-inflammatory drugs and the risk of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-06-04: Amyloid β42-level lowering non-steroidal anti-inflammatory drugs and the risk of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 15, p. 5423, doi. 10.3390/ijerph17155423
- By:
- Publication type:
- Article
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu<sup>®</sup>) among adults in THIN database of electronic UK primary healthcare records.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 1, p. 52, doi. 10.1002/pds.4347
- By:
- Publication type:
- Article
Relative Effectiveness of the MF59®‐Adjuvanted Influenza Vaccine Versus High‐Dose and Non‐Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019–2020 US Influenza Season.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 4, p. 1, doi. 10.1111/irv.13288
- By:
- Publication type:
- Article
Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 696, doi. 10.1111/irv.12969
- By:
- Publication type:
- Article
Reply to Letter to the Editor by Yin et al.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 6, p. 828, doi. 10.1111/irv.12895
- By:
- Publication type:
- Article
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 6, p. 813, doi. 10.1111/irv.12871
- By:
- Publication type:
- Article
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59<sup>®</sup>‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 1, p. 61, doi. 10.1111/irv.12685
- By:
- Publication type:
- Article
A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea.
- Published in:
- Infection & Chemotherapy, 2016, v. 48, n. 1, p. 12, doi. 10.3947/ic.2016.48.1.12
- By:
- Publication type:
- Article